Valerie DeBenedette
Valerie DeBenedette is Managing Editor of Drug Topics.
Addiction Risks Rise after Day Three of an Opioid Prescription
The length of an initial opioid prescription influences the risks of long-term use.
An Opioid Story Earns a Pulitzer
An Opioid Story Earns a Pulitzer
A reporter earned the biggest journalism prize covering the opioid crisis.
What Home DNA Tests Really Tell Us
What Home DNA Tests Really Tell Us
23andMe recently gained FDA approval, but will it actually help keep people healthier?
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses is news for pharmacists in a way that works for you.
EpiPen and EpiPen Jr. Recalled: Recall Expanded from Europe and Asia
Two previous reports of device failures lead EpiPen maker to expand recall to the United States.
WHO Launches Program to Reduce Medication Errors
How a program hopes to cut errors in half.
The Health Economics of Medical Pot and the Pharmacist’s Role
The Health Economics of Medical Pot and the Pharmacist’s Role
Even medical marijuana has health-care costs and outcomes.
What’s in the Specialty Pharmacy Pipeline?
What’s in the Specialty Pharmacy Pipeline?
Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.
Small Doses: News for Pharmacists
Small Doses: News for Pharmacists
This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.
EpiPens Recalled Overseas Due to Reported Failures
Two device failures lead Mylan to recall more than 80,000 EpiPens overseas.

Poll